GLPG0492 is primarily researched for its potential therapeutic applications in treating muscle-related conditions. It has been studied as a selective androgen receptor modulator (SARM), which means it could help in increasing muscle mass and strength without the adverse effects typically associated with anabolic steroids. This makes it a promising candidate for addressing muscle wasting diseases, such as cachexia associated with cancer or chronic illnesses, and age-related sarcopenia. Additionally, it may have applications in improving physical function and recovery in patients undergoing treatments that lead to muscle atrophy. Research is ongoing to fully understand its efficacy and safety profile in clinical settings.